EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PositiveID's Enterprise Value is $0.00 Mil.
PositiveID's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2018 was $-3.76 Mil. Therefore, PositiveID's EV-to-FCF for today is 0.00.
The historical rank and industry rank for PositiveID's EV-to-FCF or its related term are showing as below:
PSID's EV-to-FCF is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 25.22 * Ranked among companies with meaningful EV-to-FCF only.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-06-06), PositiveID's stock price is $0.0001.
PositiveID's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2018 was $-257.264. Therefore, PositiveID's PE Ratio for today is At Loss.
PositiveID EV-to-FCF Historical Data
The historical data trend for PositiveID's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, PositiveID's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PositiveID's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, PositiveID's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where PositiveID's EV-to-FCF falls into.
PositiveID EV-to-FCF Calculation
PositiveID's EV-to-FCF for today is calculated as:
PositiveID's current Enterprise Value is $0.00 Mil.
PositiveID's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.76 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PositiveID (OTCPK:PSID) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
PositiveID's share price for today is $0.0001.
PositiveID's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-257.264.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
PositiveID EV-to-FCF Related Terms
Thank you for viewing the detailed overview of PositiveID's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
PositiveID Corp is a life science tools and diagnostics company. It specializes in the biological detection and molecular diagnostic systems for homeland defense and the global healthcare market. The business activity of the firm includes the development of microfluidic systems in order to detect biological threats and outbreaks, whether airborne, in a healthcare setting, or at the point of need through its subsidiary. Further, it is also involved in the development of FireflyDX family of products, automated pathogen detection system for rapid diagnostics, both for clinical and point-of-need applications. In addition, it also manufactures specialty technology vehicles focused primarily on mobile laboratory and communications applications. All the activities are carried out through the US.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PSID has been successfully added to your 